GnRH-R Biomarker Myelin Detection Immunohistochemistry
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack an effective biomarker for searching myelin distribution, particularly in regions outside the central nervous system, and there is a need for a more precise method to investigate myelin-related diseases.
Innovation Solution
Utilizing gonadotropin-releasing hormone receptors (GnRH-R) as a biomarker, the method involves preparing tissue samples, reacting them with anti-GnRH-R antibodies, and performing immunohistochemical staining to visualize myelin distribution, which is consistent with conventional myelin-specific staining methods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional myelin staining methods (Busch's method, Loyez's method, Luxol fast blue method) are used, then myelin distribution can be visualized, but the methods are complex and require multiple staining steps
Solution Approach 1:
The patent extracts and isolates the essential function of myelin staining by using GnRH-R as a specific biomarker. Instead of using complex multi-step staining methods, the invention directly targets GnRH-R proteins in myelin through immunohistochemical staining with specific antibodies, thereby simplifying the process while maintaining detection precision.
Solution Approach 2:
The patent introduces GnRH-R as an intermediary biomarker that mediates between the staining process and myelin visualization. By using anti-GnRH-R antibodies as intermediaries, the method achieves specific myelin detection without requiring complex conventional staining procedures, thus resolving the contradiction between precision and complexity.
2Ease of operation
If GnRH-R is used as a biomarker for myelin, then the detection method becomes simpler and more direct, but the validity needs to be confirmed through comparison with conventional methods
Solution Approach 1:
The patent applies feedback by comparing the GnRH-R staining results with conventional myelin staining methods (Busch's method, Loyez's method, Luxol fast blue method). This comparative feedback validates the reliability of GnRH-R as a biomarker while maintaining the ease of operation, ensuring that the simplified method produces accurate and reliable myelin detection.
Solution Approach 2:
The patent demonstrates the universality of GnRH-R as a biomarker by showing that it can be detected using standard immunohistochemical techniques across different tissue types and disease states. This multi-functionality confirms its reliability while preserving operational simplicity, as the same basic staining protocol works for various applications.
3Measurement precision
If protein components of myelin (CNP, myelin basic protein, galactocerebroside) are used as markers, then specific myelin staining is achieved, but the staining requires specific antibody preparations and optimization
Solution Approach 1:
The patent adopts the approach of using readily available anti-GnRH-R antibodies that can be obtained through standard immunological techniques, rather than requiring complex custom antibody preparations. This makes the method easier to manufacture and implement while maintaining high specificity for myelin, as GnRH-R is a well-characterized protein with available reagents.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
GnRH-R effectively marks myelin distribution, providing a more precise and sensitive method for myelin detection, applicable for pathological studies and diagnosis of demyelination-related diseases.
Implementation Method 1
performing immunohistochemical staining to visualize myelin distribution
Data Source
AI summary
The present invention relates to a method for searching myelin using gonadotropin-releasing hormone receptors (GnRH-R) as a biomarker, more precisely, a method for investigating the distribution of myelin by immunohistochemical staining using GnRH-R antibody, based on the fact that GnRH-R and myelin are observed in the same region. The method for searching myelin of the invention can contribute to the studies on demyelination related degenerative brain disease and the disclosure of functions of myelin and the relation of myelin and GnRH-R.